ATE457992T1 - Platinkomplexe und deren verwendung in der therapie - Google Patents

Platinkomplexe und deren verwendung in der therapie

Info

Publication number
ATE457992T1
ATE457992T1 AT02760540T AT02760540T ATE457992T1 AT E457992 T1 ATE457992 T1 AT E457992T1 AT 02760540 T AT02760540 T AT 02760540T AT 02760540 T AT02760540 T AT 02760540T AT E457992 T1 ATE457992 T1 AT E457992T1
Authority
AT
Austria
Prior art keywords
platinum complexes
therapy
present
concerns novel
novel platinum
Prior art date
Application number
AT02760540T
Other languages
English (en)
Inventor
Yechezkel Barenholz
Dan Gibson
Yousef Najajreh
Elena Khazanov
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE457992T1 publication Critical patent/ATE457992T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
AT02760540T 2001-08-23 2002-08-21 Platinkomplexe und deren verwendung in der therapie ATE457992T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31411501P 2001-08-23 2001-08-23
PCT/IL2002/000687 WO2003017998A1 (en) 2001-08-23 2002-08-21 Platinum complexes and their use in cancer treatment

Publications (1)

Publication Number Publication Date
ATE457992T1 true ATE457992T1 (de) 2010-03-15

Family

ID=23218625

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02760540T ATE457992T1 (de) 2001-08-23 2002-08-21 Platinkomplexe und deren verwendung in der therapie

Country Status (9)

Country Link
US (1) US7122668B2 (de)
EP (1) EP1420775B1 (de)
JP (1) JP2005501859A (de)
AT (1) ATE457992T1 (de)
CA (1) CA2456348A1 (de)
DE (1) DE60235375D1 (de)
ES (1) ES2339228T3 (de)
IL (1) IL159993A0 (de)
WO (1) WO2003017998A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
AU2004233873B2 (en) 2003-04-25 2010-11-18 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
EP2330110A1 (de) * 2003-11-25 2011-06-08 Platco Technologies (Proprietary) Limited Platin(II) Komplexe, Herstellung und Verwendung
DK1789427T3 (da) 2004-09-01 2009-09-07 Platco Technologies Proprietar Fremstilling af platin(II)-komplekser
ES2257178B1 (es) * 2004-09-30 2007-08-16 Universidad Autonoma De Madrid Compuestos de platino de formula trans-(ptc12(isopropilamina)(4-(hidroximetil)-piridina)) y trans-(ptc12(isopropilamina)(3-hidroximetil)-piridina y su aplicacion como farmaco antitumoral.
US7956208B2 (en) * 2006-01-30 2011-06-07 Platco Technologies (Proprietary) Limited Preparation of platinum (II) complexes
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
WO2010027428A1 (en) 2008-08-26 2010-03-11 Massachusetts Institute Of Technology Platinum ( iv) complexes for use in dual mode pharmaceutical therapy
CN103917227A (zh) 2011-06-21 2014-07-09 麻省理工学院 用于治疗癌症的组合物和方法
AU2012300219A1 (en) 2011-08-26 2014-03-06 The Regents Of The University Of California Platinum anticancer agents
WO2014160216A2 (en) 2013-03-13 2014-10-02 Massachusetts Institute Of Technology Dual targeting anticancer agents
WO2014165782A2 (en) * 2013-04-05 2014-10-09 Massachusetts Institute Of Technology Compositions, methods, and kits comprising platinum compounds associated with a ligand comprising a targeting moiety
CN103360431B (zh) * 2013-07-16 2015-07-01 山西大学 一种以8-氨基喹哪啶为母体的金属配合物及其合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7304882A (de) * 1972-04-10 1973-10-12
JPS63264492A (ja) * 1986-12-18 1988-11-01 Shionogi & Co Ltd アンミン−脂環系アミン白金錯体および抗腫瘍剤
CA1327039C (en) 1986-12-18 1994-02-15 Tetsushi Totani Ammine-alicyclic amine-platinum complexes and antitumor agents
US4921963A (en) * 1987-04-13 1990-05-01 British Columbia Cancer Foundation Platinum complexes with one radiosensitizing ligand
US5026694A (en) * 1987-04-13 1991-06-25 The British Columbia Cancer Foundation Platinum complexes with one radiosensitizing ligand
GB9502799D0 (en) 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
JP2006504691A (ja) * 2002-09-11 2006-02-09 ボード オブ リージェンツ ザ ユニバーシティー オブ テキサス システム 生化学的調節と組合せた抗腫瘍剤としての白金錯体

Also Published As

Publication number Publication date
CA2456348A1 (en) 2003-03-06
US20050090478A1 (en) 2005-04-28
DE60235375D1 (de) 2010-04-01
EP1420775A1 (de) 2004-05-26
IL159993A0 (en) 2004-06-20
JP2005501859A (ja) 2005-01-20
ES2339228T3 (es) 2010-05-18
EP1420775B1 (de) 2010-02-17
WO2003017998A1 (en) 2003-03-06
WO2003017998B1 (en) 2003-08-28
US7122668B2 (en) 2006-10-17

Similar Documents

Publication Publication Date Title
DE60235375D1 (de) Platinkomplexe und deren verwendung in der therapie
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
ATE469892T1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
ATE466085T1 (de) Protease-resistente modifizierte interferon alpha polypeptide
MY127718A (en) Dolastatin 10 derivatives.
CR6540A (es) Trifluorobutenos nematicidas
NO20013443D0 (no) Triazolforbindelser med dopamin-D3-reseptoraktivitet
DE69834269D1 (de) Piperidinylsubstituierte pyridylalkan-, -alken- und -alkincarbonsäuren als cytostatika und immunsuppressiva
MXPA04002982A (es) Derivados de pirrolidinona.
ATE291024T1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
DE60218633D1 (de) Inhibitoren von cruzipain und anderen cysteinproteasen
ATE396205T1 (de) Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe
ATE495187T1 (de) Dalda-analoge und ihre verwendung
SE9703414D0 (sv) New compounds
ATE319718T1 (de) Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore
DK1379508T3 (da) N-(aryl)-2arylethensulfonamider og terapeutiske anvendelser deraf
ATE333901T1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
ATE269340T1 (de) Thiazolopyrimidine und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
MY136297A (en) Piperazine derivatives having sst1 antagonistic activity
DE69725457D1 (de) Piperazinderivate als neurokinin-antagonisten
BG105710A (en) 5ht1 antagonists for antidepressant therapy
DE50310038D1 (de) Hemmstoffe der urokinase, ihre herstellung und verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties